Author: Gascoigne M.H. Holland K. Page C.P. Shock A. Robinson M. Foulkes R. Gozzard N.
Publisher: Elsevier
ISSN: 1094-5539
Source: Pulmonary Pharmacology & Therapeutics, Vol.16, Iss.5, 2003-10, pp. : 279-285
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Natalizumab: AN 100226, Anti-4 Integrin Monoclonal Antibody
Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. :